Results 151 to 160 of about 2,396 (188)
Some of the next articles are maybe not open access.
Sustained release of Amobarbital
To address this problem, an implantable, PLGA-based dosage form providing sustained administration of amobarbital has been developed. The hypothesis is that this strategy can moderate oxidant overproduction over longer timeframes and subsequently block PTOA development following less severe joint trauma.openaire +1 more source
HPLC analysis for amobarbital N-glycosides in urine
Journal of Pharmaceutical and Biomedical Analysis, 1997William H Soiné
exaly